NDC 53808-1119
Norvir
Ritonavir
Norvir is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Doh Central Pharmacy. The primary component is Ritonavir.
| Product ID | 53808-1119_ba727e7e-57cc-4564-afd1-9464f34f4d7d |
| NDC | 53808-1119 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Norvir |
| Generic Name | Ritonavir |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-01-09 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022417 |
| Labeler Name | DOH CENTRAL PHARMACY |
| Substance Name | RITONAVIR |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | HIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],UDP Glucuronosyltransferases Inducers [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
Packaging
NDC 53808-1119-1
30 TABLET, FILM COATED in 1 BLISTER PACK (53808-1119-1)
| Marketing Start Date | 2018-01-09 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 53808-1119-1 [53808111901]
Norvir TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA022417 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-01-09 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| RITONAVIR | 100 mg/1 |
OpenFDA Data
| SPL SET ID: | bc00d131-afc3-457f-b18f-065775af6f1c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Pharmacological Class
- HIV Protease Inhibitors [MoA]
- Cytochrome P450 3A Inhibitor [EPC]
- Protease Inhibitor [EPC]
- Cytochrome P450 3A Inhibitors [MoA]
- Cytochrome P450 2D6 Inhibitors [MoA]
- Cytochrome P450 2C19 Inducers [MoA]
- Cytochrome P450 3A Inducers [MoA]
- P-Glycoprotein Inhibitors [MoA]
- Breast Cancer Resistance Protein Inhibitors [MoA]
- Cytochrome P450 3A4 Inhibitors [MoA]
- Cytochrome P450 1A2 Inducers [MoA]
- Cytochrome P450 2C9 Inducers [MoA]
- Cytochrome P450 2B6 Inducers [MoA]
- UDP Glucuronosyltransferases Inducers [MoA]
- HIV Protease Inhibitors [MoA]
- Cytochrome P450 3A Inhibitor [EPC]
- Protease Inhibitor [EPC]
- Cytochrome P450 3A Inhibitors [MoA]
- Cytochrome P450 2D6 Inhibitors [MoA]
- Cytochrome P450 2C19 Inducers [MoA]
- Cytochrome P450 3A Inducers [MoA]
- P-Glycoprotein Inhibitors [MoA]
- Breast Cancer Resistance Protein Inhibitors [MoA]
- Cytochrome P450 3A4 Inhibitors [MoA]
- Cytochrome P450 1A2 Inducers [MoA]
- Cytochrome P450 2C9 Inducers [MoA]
- Cytochrome P450 2B6 Inducers [MoA]
- UDP Glucuronosyltransferases Inducers [MoA]
NDC Crossover Matching brand name "Norvir" or generic name "Ritonavir"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0074-1940 | Norvir | Ritonavir |
| 0074-2340 | Norvir | Ritonavir |
| 0074-3333 | Norvir | Ritonavir |
| 0074-3399 | Norvir | Ritonavir |
| 50090-1162 | Norvir | Ritonavir |
| 53808-1119 | Norvir | Ritonavir |
| 67296-1234 | Norvir | Norvir |
| 0054-0407 | Ritonavir | Ritonavir |
| 31722-597 | Ritonavir | Ritonavir |
| 60687-364 | Ritonavir | Ritonavir |
| 60687-420 | Ritonavir | Ritonavir |
| 65162-061 | Ritonavir | Ritonavir |
| 65862-687 | Ritonavir | Ritonavir |
Trademark Results [Norvir]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 NORVIR 74655713 2001944 Live/Registered |
ABBVIE INC. 1995-04-04 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.